With COVID-19 having brought sharply into focus the value of our health, individually, to society and economies there’s a renewed focus on how we spend public money on healthcare in Europe. EFPIA (the European Federation of Pharmaceutical Industries and Associations) wants to use this moment of reflection to prompt a re-think and rebuild support for Intellectual property laws.